Profile
LYRA VRTX REGN SGEN ALNY ARGX
Company Name Lyra Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $12.07M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.03K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Maria Palasis Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
LYRA VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 2
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Sell
Trading
LYRA VRTX REGN SGEN ALNY ARGX
Last Close $9 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $27.58 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.08 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -67.37 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 11150 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
LYRA VRTX REGN SGEN ALNY ARGX
1 Month Return -62.93 % 2.02 % 10.98 % 0 % 10.33 % -7.24 %
3 Month Return 7362.69 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return 3961.37 % 14.19 % -23.58 % 0 % 42.36 % -15.79 %
9 Month Return 3691.07 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return 4260.47 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return 3208.82 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LYRA VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -298.4 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
LYRA VRTX REGN SGEN ALNY ARGX
Asset Growth -53.47 % -0.87 % 36.55 %
Gross Profit Growth -31.77 % 10.25 % 77.08 %
Revenue Growth -1.54 % 11.66 % 78.6 %
Revenue 3 Year 7.35 % 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year -88.13 % 1632.15 % 5950.81 %
EBIT Growth 7.32 % -93.69 % 128.87 %
Net Income Growth -49.07 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 56.06 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 27.04 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -49.15 % 33.84 % 938.02 %
Operating Income Growth -43.55 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -10.59 % -113.93 % 80.31 %
Operating 3 Year CFG 45.92 % -118.65 % 88.36 %
Operating 5 Year CFG 36.03 % -131.3 % -135.21 %
Operating 10 Year CFG -1.47 % 12.43 % -64 %
EPS Growth 100 % -114.8 % 369.77 %
EPS Diluted Growth 100 % -114.97 % 347.67 %
Book Value Per Share -90.09 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -93.26 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -80.12 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 101.04 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 27.9 % 116.42 % 95.27 %
Free Cash Flow Growth -12.43 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
LYRA VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM -1019.32 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -141.22 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -474.37 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -182.1 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100.04 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 97.35 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -6891.56 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -169.08 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 18.3 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 5.8 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 2.1 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -42.88 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -43.03 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 2413.01 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -4759.32 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -169.08 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.21 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.21 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.21 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
LYRA VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 69.3% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.09B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted - -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
LYRA VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.06B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.05B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.01B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.03B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.07B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
LYRA VRTX REGN SGEN ALNY ARGX
Net Income $-0.09B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to LYRA
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 223.08
VTI Vanguard Total Stock Market Index Fund 0 308.03
IWO iShares Russell 2000 Growth ETF 0.00015 292.05
VXF Vanguard Extended Market Index Fund 0.00004 197.5
HDG ProShares Hedge Replication ETF 0.0000412346 49.8565
UWM ProShares Ultra Russell2000 0.000106295 40.22
IWC iShares Micro-Cap ETF 0.00055 133.14
DWAS Invesco DWA SmallCap Momentum ETF 0.018 86.02
URTY ProShares UltraPro Russell2000 0.0000613179 43.37
VTWV Vanguard Russell 2000 Value Index Fund 0.00021 145.53
VTWG Vanguard Russell 2000 Growth Index Fund 0.00049 213.24
VTWO Vanguard Russell 2000 Index Fund 0.00019 90.18
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 42.29
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.17
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.16
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.17
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.14 72.5283
DFAU Dimensional US Core Equity Market ETF 0.00000991 42.97
DFUS Dimensional U.S. Equity ETF 0.0000173 67.95
DFAT Dimensional U.S. Targeted Value ETF 0.00008 56.35
DFAS Dimensional U.S. Small Cap ETF 0.00006233 65.87
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002207 36.52
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
DFSU Dimensional US Sustainability Core 1 ETF 0 39.96
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000127257 106.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 149.83
DCOR Dimensional ETF Trust 0.00000067 68.05
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
RSSL Global X Funds 0 87.32
Unlock